Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Complement and coagulation cascades | R-HSA-114591 | map04610 | STOCK1N-28457 | None | drug-path |
| SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | pyrantel | 54682938 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | pyrantel | 54682938 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | pyrantel | 54682938 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | pyrantel | 54682938 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | pyrantel | 54682938 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | pyrantel | 54682938 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | tiratricol | 5803 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | tiratricol | 5803 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | tiratricol | 5803 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | tiratricol | 5803 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | tiratricol | 5803 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | tiratricol | 5803 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | tiratricol | 5803 | drug-path |
| Asthma | R-HSA-444620 | map05310 | tiratricol | 5803 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | tiratricol | 5803 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | tiratricol | 5803 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | levamisole | 26879 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | levamisole | 26879 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | levamisole | 26879 | drug-path |